Last edition
News about "Emcure Gains Commercial Rights for Roche Brands in"
Strategic Licensing Boost: Emcure Gains Commercial Rights for Roche Brands in India
Under the agreement, Emcure will acquire commercial rights to several branded prescription medicines used in the management of kidney diseases and in post-transplant care for patients in India. The deal strengthens Emcure’s presence in high-priority therapeutic areas and expands its portfolio in nephrology and transplant medicine.
Emcure Gains Commercial Rights For Roche Brands In | 03/03/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy